Skip to main content
. 2014 Apr 7;8:141–153. doi: 10.2147/BTT.S37509

Figure 2.

Figure 2

Properties of tocilizumab and tumor necrosis factor inhibitors in the management of rheumatoid arthritis.

Abbreviations: AEs, adverse events; CRP, C-reactive protein; GI, gastrointestinal; MTX, methotrexate; SAA, serum amyloid A; TB, tuberculosis; T-CHO, total cholesterol.